Over the last decade, value-based reimbursement models have garnered a mountain of interest, but challenges in building a data infrastructure that can identify outcome metrics and logistics to dispense payments have largely relegated these models to anecdotal status. Recent deals by Pfizer and Takeda may indicate a step forward. Precision's Ryan Cox weighs in on the evolving state of value based reimbursement models.
Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision's Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.
Listen as PRECISIONvalue's Mike Chambers sits down with Ethan Beute, host of The Customer Experience Podcast, to discuss why relationship and responsiveness are at the center of customer experience, as well as other key insights regarding sales strategies.
PRECISIONvalue’s 2021 Care Management Survey found that Oncology was the top condition for which patients were referred for Care Management, and tools, resources and programs for supporting medication adherence were the top type of support that respondents would like to receive from pharmaceutical manufacturers.
Are you attending LTEN 2021, November 8-11? Don't miss the workshop "Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D" on Wednesday, 11/10 at 3:30pm MST | 5:30pm EDT in the Cottonwood 6 room!
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
